Work

Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype

Year: 1994

Type: article

Study design: Observational Study

Source: Human Molecular Genetics

DOI: 10.1093/hmg/3.6.923

Authors: Richa Saxena, Gall L. Shaw, Mary V. Relling, James N. Frame, Donald T. Moir, William E. Evans, Neil Caporaso, Barbara Weiffenbach

Institutions: National Cancer Institute, St. Jude Children's Research Hospital, Walter Reed National Military Medical Center, Division of Cancer Epidemiology and Genetics

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: DNA PROBE TEST FOR DEBRISOQUINE HYDROXYLASE PHENOTYPE, G609259107, PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL), G8309927422, Cancer Center Support Grant (CCSG)

OpenAlex ID: W2117918458

FWCI: 8.778

Cites:

Cited by: 100

Related to: 10